Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
US Department of Justice
Julphar
Chubb
Medtronic
Queensland Health
McKinsey
Baxter

Generated: June 25, 2018

DrugPatentWatch Database Preview

NEPHRAMINE 5.4% Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nephramine 5.4%, and what generic alternatives are available?

Nephramine 5.4% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in NEPHRAMINE 5.4% is amino acids. There are three hundred and forty-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for NEPHRAMINE 5.4%
Drug patent expirations by year for NEPHRAMINE 5.4%

US Patents and Regulatory Information for NEPHRAMINE 5.4%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun NEPHRAMINE 5.4% amino acids INJECTABLE;INJECTION 017766-001 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chubb
McKinsey
UBS
Queensland Health
Argus Health
Covington
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.